EMJ Oncology [Supplement 3] . 2022

In this issue

In this interview, they discuss the role of direct oral anticoagulants (DOAC) as a treatment for cancer-associated thrombosis (CAT), including updates to the guidelines and the importance of patient-centric care. A discussion of key unmet needs as described by the two experts and a look to the future of anticoagulation in patients with cancer is also included.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.